Welcome to the Phacilitate Vaccine Forum Geneva 2008

Comments from participants in the 2007 event included:

"Excellent. The best"
Dr Michael Balady, Acting Deputy Director, Medical Countermeasures, Office of Public Health Emergency Medical Countermeasures, Office of the Assistant Secretary for Preparedness & Response (ASPR), US Department of Health & Human Services

"Very well organised, covering hot topics and with ample opportunity for networking. A vibrant atmosphere"
Dr Hilde De Winter, Director, Clinical Development & Medical Affairs, Innogenetics

"Outstanding – up-to-date and ideal for networking"
Dr Olav Zilian, Finance Analyst – Biotech, Helvea

"I continue to find Phacilitate vaccine meetings to have strong speakers and agendas on a range of very timely topics"
Dr Ronald W. Ellis, Senior Vice President, Research & Development, AVANT Immunotherapeutics, Inc

"Excellent opportunity to connect with the vaccine industry’s key players and to network"
Dr Silke Fetzer, Head of Product Management, Cell Culture & Vaccine Operational Marketing, GE Healthcare

"Very good quality and mix of public/private sector speakers"
Peter Brazier, CEO, NewBiomed PIKA Pte Ltd

Top